Skip to main content
Equibles
JRSS logo

JRSS · JRSIS HEALTH CARE Corp

Track JRSS — free

Use JRSS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.02 At close · Sep 2
Rebalance outlook locked
Going-concern doubt — flagged Dec 20, 2024

Substantial doubt about the company's ability to continue as a going concern.

“Management believes these factors raise substantial doubt about the Company's ability to continue as a going concern for the next twelve months. These conditions raise substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Dec 20, 2024
Market Cap
$1.27M
Shares
84.60M

JRSS metrics

47 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.02
Market cap
$1.27M

Price action

19 metrics
Price change (1W)
—
Price change (30D)
—
Price change (3M)
-88.5%
Price change (6M)
+50.0%
Price change (YTD)
-17.1%
Price change (1Y)
+150.0%
Trailing year
Price change (5Y)
—
52-week high
$0.13
52-week low
$0.01
Change from 52-week high
-88.5%
Change from 52-week low
+150.0%
Annualized volatility
—
Beta
—
RSI (14D)
44.4
Price vs SMA 50
-43.2%
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Consumer Cyclical
Industry
Specialty Retail
Shares outstanding
84.60M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.4×
reciprocal yield 223.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 227.9%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-33.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
12.7%
Operating margin
-19.5%
Trailing 12 months
Net margin
-14.5%
Gross profit (TTM)
$442,158
Operating profit (TTM)
−$675,664
Net income (TTM)
−$503,656
Trailing 12 months
Diluted EPS (TTM)
$-0.01
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.00

Growth

11 metrics
Revenue growth YoY
-55.2%
Year over year
Net income growth YoY
-658.2%
Revenue (TTM)
$3.47M
Trailing 12 months
EPS growth YoY
-650.0%
Shares change YoY
+10.2%
Year over year · more shares
Revenue CAGR (3Y)
-54.1%
Revenue CAGR (5Y)
-34.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-39.9%
FCF CAGR (5Y)
-38.6%

Quality

14 metrics
Return on equity
—
Return on assets
-24.3%
Debt / equity
—
Current ratio
0.8
EBITDA (TTM)
−$604,101
Free cash flow (TTM)
—
Quick ratio
0.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$30,182
Latest balance sheet
Cash & equivalents
$1,372
Total assets
$2.07M
Total debt
$31,554

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$730,303
Capital expenditures (TTM)
—
R&D (TTM)
$133,118
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
3.8%
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1597892

Report a Problem

Category
Description
Email (optional, for follow-up)